HuGE Literature Finder
Records
1
-
1
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients. Pharmacological research 2016 Jul . Alicja Puszkiel, Mélanie White-Koning, Nicolas Dupin, Nora Kramkimel, Audrey Thomas-Schoemann, Gaëlle Noé, Nicolas Chapuis, Michel Vidal, François Goldwasser, Etienne Chatelut, Benoit Blanch |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: